1-Deamino-1-hydroxy-aminoglycoside compounds, antibacterial compositions and method of use
AssigneeBristol-Myers Company
InventorsMinoru Hanada, Mitsuaki Tsunakawa, Koji Tomita, Hiroshi Tsukiura, Hiroshi Kawaguchi
Life of this patent
Estimating the term…
Abstract
Antibiotic Bu-2659 complex, containing components A, B, C, D and E, is produced by cultivation of Streptomyces hygroscopicus Strain No. J296-21, ATCC No. 39150.
Claims8
Antibiotic Bu-2659 complex comprising a mixture of 1-deamino-1-hydroxyneomycin B, 1-deamino-1-hydroxyneomycin C, 1-deamino-1-hydroxyparomomycin I, 1,6'"-dideamino-1,6'"-dihydroxyneomycin B and 1-deamino-1-hydroxyribostamycin, or an acid addition salt thereof.
1-Deamino-1-hydroxyneomycin B or a pharmaceutically acceptable acid addition salt thereof.
1-Deamino-1-hydroxyneomycin C or a pharmaceutically acceptable acid addition salt thereof.
1-Deamino-1-hydroxyparomomycin I or a pharamaceutically acceptable acid addition salt thereof.
1,6'"-Dideamino-1,6'"-dihydroxyneomycin B or a pharmaceutically acceptable acid addition salt thereof.
1-Deamino-1-hydroxyribostamycin or a pharmaceutically acceptable acid addition salt thereof.
A method of treating a bacterial infection in a mammal in need of same which comprises administering to said mammal an antibacterially effective amount of 1-deamino-1-hydroxyneomycin B or a pharmaceutically acceptable acid addition salt thereof.
An antibacterial composition comprising an antibacterially effective amount of 1-deamino-1-hydroxyneomycin B, or a pharmaceutically acceptable acid addition salt thereof, and a pharmaceutically acceptable carrier.
Dependencies are inferred from the claim text.